Please Wait
Applying Filters...
menu
    • menu
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.

    Virtual Booth

    Contact Supplier

    Menu

    ALZ-801

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alzheon to Present ALZ-801 Data at AAIC Toronto
    Alzheon to Present ALZ-801 Data at AAIC Toronto

    15 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250715240263/en/Alzheon-to-Present-Insights-into-Oral-ValiltramiprosateALZ-801-Mode-of-Action-and-Clinical-Efficacy-at-Dedicated-Symposium-at-Alzheimers-Association-International-Conference-in-Toronto-on-July-30th-2025

    BUSINESSWIRE
    15 Jul 2025
    Share Share
    Alzheon To Present APOLLOE4 Ph3 Data At ADPD On April 1
    Alzheon To Present APOLLOE4 Ph3 Data At ADPD On April 1

    18 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250318710720/en/Alzheon-to-Present-Results-from-Pivotal-APOLLOE4-Phase-3-Trial-of-Oral-ValiltramiprosateALZ-801-at-Dedicated-Symposium-at-ADPD-Conference-in-Vienna-on-April-1st-2025

    BUSINESSWIRE
    18 Mar 2025
    Share Share
    Alzheon Publishes Two Papers Ahead Ph 3 Topline Data At ADPD
    Alzheon Publishes Two Papers Ahead Ph 3 Topline Data At ADPD

    25 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250225250957/en

    BUSINESSWIRE
    25 Feb 2025
    Share Share
    Anokion Presents ANK-700 Data For Multiple Sclerosis
    Anokion Presents ANK-700 Data For Multiple Sclerosis

    18 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240917374019/en

    BUSINESSWIRE
    18 Sep 2024
    Share Share
    Alzheon To Present ALZ-801 Trial Results At Alzheimer's Conference
    Alzheon To Present ALZ-801 Trial Results At Alzheimer's Conference

    23 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240723403529/en

    BUSINESSWIRE
    23 Jul 2024
    Share Share
    Alzheon Raises $100M Series E For Alzheimer's Drug Development
    Alzheon Raises $100M Series E For Alzheimer's Drug Development

    12 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240612246496/en

    BUSINESSWIRE
    12 Jun 2024
    Share Share